These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8760592)

  • 1. Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not c-raf-1 protein.
    Warenius HM; Seabra LA; Maw P
    Int J Cancer; 1996 Jul; 67(2):224-31. PubMed ID: 8760592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
    Aziz N; Cherwinski H; McMahon M
    Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-raf-1 proto-oncogene expression relates to radiosensitivity rather than radioresistance.
    Warenius HM; Browning PG; Britten RA; Peacock JA; Rapp UR
    Eur J Cancer; 1994; 30A(3):369-75. PubMed ID: 8204361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
    Wingett D; Long A; Kelleher D; Magnuson NS
    J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
    Ikeguchi M; Nakamura S; Kaibara N
    Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
    Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
    Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
    Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
    Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of the RAF1 proto-oncogene.
    Warenius HM; Jones MD; Thompson CC
    Radiat Res; 1996 Nov; 146(5):485-93. PubMed ID: 8896574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
    Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the cell cycle machinery by oncogenic ras.
    Winston JT; Coats SR; Wang YZ; Pledger WJ
    Oncogene; 1996 Jan; 12(1):127-34. PubMed ID: 8552383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.